These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 8077542)
1. Effect of shock timing on efficacy and safety of internal cardioversion for ventricular tachycardia. Li HG; Yee R; Mehra R; DeGroot P; Klein GJ; Zardini M; Thakur RK; Morillo CA J Am Coll Cardiol; 1994 Sep; 24(3):703-8. PubMed ID: 8077542 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms of ventricular tachycardia termination and acceleration during transvenous cardioversion as determined by cardiac mapping in man. Saksena S; Pantopoulos D; Hussain SM; Gielchinsky I Am Heart J; 1987 Jun; 113(6):1495-506. PubMed ID: 3591617 [TBL] [Abstract][Full Text] [Related]
3. Safety of transvenous low energy cardioversion of atrial fibrillation in patients with a history of ventricular tachycardia: effects of rate and repolarization time on proarrhythmic risk. Simons GR; Newby KH; Kearney MM; Brandon MJ; Natale A Pacing Clin Electrophysiol; 1998 Feb; 21(2):430-7. PubMed ID: 9507545 [TBL] [Abstract][Full Text] [Related]
4. Timing of defibrillation shocks for resuscitation of rapid ventricular tachycardia: does it make a difference? Turner I; Turner S; Grace AA Resuscitation; 2009 Feb; 80(2):183-8. PubMed ID: 19091453 [TBL] [Abstract][Full Text] [Related]
5. A prospective evaluation of single and dual current pathways for transvenous cardioversion in rapid ventricular tachycardia. Saksena S; Calvo RA; Pantopoulos D; Gadhoke A; Rothbart ST Pacing Clin Electrophysiol; 1987 Sep; 10(5):1130-41. PubMed ID: 2444937 [TBL] [Abstract][Full Text] [Related]
6. Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation. Ayers GM; Alferness CA; Ilina M; Wagner DO; Sirokman WA; Adams JM; Griffin JC Circulation; 1994 Jan; 89(1):413-22. PubMed ID: 8281677 [TBL] [Abstract][Full Text] [Related]
7. Prospective evaluation of a sequential pacing and high-energy bidirectional shock algorithm for transvenous cardioversion in patients with ventricular tachycardia. Lindsay BD; Saksena S; Rothbart ST; Wasty N; Pantopoulos D Circulation; 1987 Sep; 76(3):601-9. PubMed ID: 3621521 [TBL] [Abstract][Full Text] [Related]
8. Ventricular fibrillation induced by low-energy shocks from programmable implantable cardioverter-defibrillators in patients with coronary artery disease. Lauer MR; Young C; Liem LB; Ottoboni L; Peterson J; Goold P; Sung RJ Am J Cardiol; 1994 Mar; 73(8):559-63. PubMed ID: 8147300 [TBL] [Abstract][Full Text] [Related]
9. Activation of the right ventricular apical electrogram during ventricular tachycardia: suitability for synchronizing intracavitary cardioversion. Sharma AD; Klein GJ; Milstein S; MacDonald A Pacing Clin Electrophysiol; 1985 Mar; 8(2):186-91. PubMed ID: 2580279 [TBL] [Abstract][Full Text] [Related]
10. High dispersion of ventricular repolarization after an implantable defibrillator shock predicts induction of ventricular fibrillation as well as unsuccessful defibrillation. Moubarak JB; Karasik PE; Fletcher RD; Franz MR J Am Coll Cardiol; 2000 Feb; 35(2):422-7. PubMed ID: 10676690 [TBL] [Abstract][Full Text] [Related]
11. Clinical transvenous cardioversion of recurrent life-threatening ventricular tachyarrhythmias: low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrode. Zipes DP; Jackman WM; Heger JJ; Chilson DA; Browne KF; Naccarelli GV; Rahilly GT; Prystowsky EN Am Heart J; 1982 May; 103(5):789-94. PubMed ID: 7072583 [TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of dual electrode systems for endocardial cardioversion of ventricular tachycardia: a prospective randomized crossover trial. Saksena S; An H Am Heart J; 1990 Jan; 119(1):15-22. PubMed ID: 2404386 [TBL] [Abstract][Full Text] [Related]
13. Low-energy endocardial defibrillation using dual, triple, and quadruple electrode systems. Munsif AN; Saksena S; DeGroot P; Krol RB; Matthew P; Giorgberidze I; Kaushik RR; Mehra R Am J Cardiol; 1997 Jun; 79(12):1632-9. PubMed ID: 9202354 [TBL] [Abstract][Full Text] [Related]
14. A prospective randomized study of the clinical efficacy and safety of transvenous cardioversion for termination of ventricular tachycardia. Ciccone JM; Saksena S; Shah Y; Pantopoulos D Circulation; 1985 Mar; 71(3):571-8. PubMed ID: 3971528 [TBL] [Abstract][Full Text] [Related]
15. [Sustained ventricular tachycardia: low-energy transcatheter internal cardioversion. Efficacy, reliability and tolerance in comparison with ventricular burst]. Vergara G; Disertori M; Inama G; Guarnerio M; Stirpe E; Furlanello F G Ital Cardiol; 1985 Sep; 15(9):862-72. PubMed ID: 4085732 [TBL] [Abstract][Full Text] [Related]
16. [Shock-induced, but not terminated ventricular tachycardia in a patient with implantable defibrillator]. Kühlkamp V; Dörnberger V; Mermi J; Mewis C; Seipel L Z Kardiol; 1996 May; 85(5):306-11. PubMed ID: 8711942 [TBL] [Abstract][Full Text] [Related]
17. Transvenous internal cardioversion for atrial fibrillation: a randomized study on defibrillation threshold and tolerability of asymmetrical compared with symmetrical shocks. Boriani G; Biffi M; Zannoli R; Branzi A; Magnani B Int J Cardiol; 1999 Sep; 71(1):63-9. PubMed ID: 10522566 [TBL] [Abstract][Full Text] [Related]
18. Ventricular tachycardia rate and morphology determine energy and current requirements for transthoracic cardioversion. Kerber RE; Kienzle MG; Olshansky B; Waldo AL; Wilber D; Carlson MD; Aschoff AM; Birger S; Fugatt L; Walsh S Circulation; 1992 Jan; 85(1):158-63. PubMed ID: 1728445 [TBL] [Abstract][Full Text] [Related]
19. Endocardial pacing, cardioversion and defibrillation using a braided endocardial lead system. Saksena S; Luceri R; Krol RB; Brownstein S; Burkhardt E; Accorti P; Brewer G; Scott S; Callaghan F; Livingston A Am J Cardiol; 1993 Apr; 71(10):834-41. PubMed ID: 8456763 [TBL] [Abstract][Full Text] [Related]
20. Prospective comparison of biphasic and monophasic shocks for implantable cardioverter-defibrillators using endocardial leads. Saksena S; An H; Mehra R; DeGroot P; Krol RB; Burkhardt E; Mehta D; John T Am J Cardiol; 1992 Aug; 70(3):304-10. PubMed ID: 1632393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]